3,626
Views
50
CrossRef citations to date
0
Altmetric
Clinical Research

Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series

, , , , , & ORCID Icon show all
Pages 908-913 | Received 23 Dec 2016, Accepted 21 Apr 2017, Published online: 11 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Guillermo Burillo-Putze, John R. Richards, Consuelo Rodríguez-Jiménez & Alejandro Sanchez-Agüera. (2022) Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature. Expert Opinion on Pharmacotherapy 23:6, pages 693-702.
Read now
Samantha Wagner, Jason Hoppe, Matthew Zuckerman, Kerry Schwarz & Julie McLaughlin. (2020) Authors’ response to “Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department”. Clinical Toxicology 58:9, pages 939-939.
Read now
Samantha Wagner, Jason Hoppe, Matthew Zuckerman, Kerry Schwarz & Julie McLaughlin. (2020) Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department. Clinical Toxicology 58:6, pages 471-475.
Read now
Carl Lee, Shaun L. Greene & Anselm Wong. (2019) The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome. Clinical Toxicology 57:9, pages 773-777.
Read now
John R. Richards, Jeff M. Lapoint & Guillermo Burillo-Putze. (2018) Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment. Clinical Toxicology 56:1, pages 15-24.
Read now
Josh J. Wang, Eric Villeneuve, Jacques-Alexandre Amiel & Sophie Gosselin. (2018) Cannabinoid hyperemesis syndrome and topical capsaicin: treating smoke with fire?. Clinical Toxicology 56:1, pages 78-78.
Read now

Articles from other publishers (44)

Emilie Bouquet, Emilie Jouanjus & Maryse Lapeyre-Mestre. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment 127 138 .
Kathleen Louis-Gray, Srinivasan Tupal & Louis S. Premkumar. (2022) TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids. International Journal of Molecular Sciences 23:17, pages 10016.
Crossref
Allison Lee & Zlatan Coralic. (2021) Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department. Annals of Pharmacotherapy 56:2, pages 151-154.
Crossref
Sakshi Yadav, Anuj Ajayababu, Tej Prakash Sinha & Sanjeev Bhoi. 2022. Pain Management - From Pain Mechanisms to Patient Care [Working Title]. Pain Management - From Pain Mechanisms to Patient Care [Working Title].
Sasha Kaiser & Andrew Monte. 2022. Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis. Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis 217 239 .
Esezah Kakudidi, Patience Tugume, Savina Asiimwe & Godwin Anywar. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare 189 210 .
Heather Murray & Thida Thant. 2022. Cannabis in Psychiatric Practice. Cannabis in Psychiatric Practice 153 163 .
Vivian Kum, Adrienne Bell, Wei Fang & Elizabeth VanWert. (2021) Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department. The American Journal of Emergency Medicine 49, pages 343-351.
Crossref
Janice L. Stumpf & Lauren D. Williams. (2020) Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin. Journal of Pharmacy Practice 34:5, pages 786-793.
Crossref
Kaushal Dosani, Carolina Koletic & Rabea Alhosh. (2021) Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem. Pediatrics In Review 42:9, pages 500-506.
Crossref
Erin M. RockCheryl L. LimebeerRoger G. PertweeRaphael MechoulamLinda A. Parker. (2021) Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting. Cannabis and Cannabinoid Research 6:4, pages 266-274.
Crossref
Brian Lewis, Erin Leach, Larissa B. Fomum Mugri, Man Yee Keung, Lindsey Ouellette, Brad Riley, Bryan Judge, Tiffany Fleeger & Jeffrey S. Jones. (2021) Community-based study of cannabis hyperemesis syndrome. The American Journal of Emergency Medicine 45, pages 504-505.
Crossref
Aaron J. Ruberto, Marco L.A. Sivilotti, Savannah Forrester, Andrew K. Hall, Frances M. Crawford & Andrew G. Day. (2021) Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial. Annals of Emergency Medicine 77:6, pages 613-619.
Crossref
Nathaniel Leu & Joanne C. Routsolias. (2021) Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment. Journal of Emergency Nursing 47:3, pages 483-486.
Crossref
Hamzah M. Yusuf, Curtis Geier, Alex Staidle & Juan Carlos C. Montoy. (2021) Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: A retrospective cohort study. The American Journal of Emergency Medicine 43, pages 142-148.
Crossref
Ali Pourmand, Gabriel Esmailian, Maryann Mazer-Amirshahi, Owen Lee-Park & Quincy K. Tran. (2021) Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis. The American Journal of Emergency Medicine 43, pages 35-40.
Crossref
Jennifer Hsu, Zachary Herrmann, Saurabh Kashyap & Cynthia Claassen. (2021) Treatment of Cannabinoid Hyperemesis With Olanzapine: A Case Series. Journal of Psychiatric Practice 27:4, pages 316-321.
Crossref
Julien Flament, Nathan Scius & Henri Thonon. (2020) Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review. International Journal of Emergency Medicine 13:1.
Crossref
Mahesh Gajendran, Joshua Sifuentes, Mohammad Bashashati & Richard McCallum. (2023) Cannabinoid Hyperemesis Syndrome: Definition, Pathophysiology, Clinical Spectrum, Insights into Acute and Long-Term Management. Journal of Investigative Medicine 68:8, pages 1309-1316.
Crossref
Ansar Aziz, Tayyab Waheed, Olubunmi Oladunjoye, Adeolu Oladunjoye, Midhat Hanif & Fareena Latif. (2020) Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome. Case Reports in Gastrointestinal Medicine 2020, pages 1-4.
Crossref
Diana J. Dean, Noor Sabagha, Kaitlin Rose, Alexander Weiss, John France, Timothy Asmar, Jo‐Ann Rammal, Margaret Beyer, Rebecca Bussa, Jacob Ross, Kaleem Chaudhry, Thomas Smoot, Kathleen Wilson & Joseph Miller. (2020) A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome. Academic Emergency Medicine 27:11, pages 1166-1172.
Crossref
Rory Stuart & John Ray Richards. (2020) Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting—A Case Report. Military Medicine 185:9-10, pages e1894-e1896.
Crossref
Sadhana Dharmapuri, Kathleen Miller & Jonathan D. Klein. (2020) Marijuana and the Pediatric Population. Pediatrics 146:2.
Crossref
Marieka V. DeVuonoLinda A. Parker. (2020) Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms. Cannabis and Cannabinoid Research 5:2, pages 132-144.
Crossref
Karen Randall, Brad Roberts & John Cienki. 2020. Cannabis in Medicine. Cannabis in Medicine 157 170 .
Sean M. McConachie, Ryan A. Caputo, Sheila M. Wilhelm & Pramodini B. Kale-Pradhan. (2019) Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Annals of Pharmacotherapy 53:11, pages 1145-1152.
Crossref
Yaniv Chocron, Jean-Philippe Zuber & Julien Vaucher. (2019) Cannabinoid hyperemesis syndrome. BMJ, pages l4336.
Crossref
Khala Albert, Marco L.A. Sivilotti, Joey Gareri, Andrew Day, Aaron J. Ruberto & Lawrence C. Hookey. (2019) Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome. CJEM 21:4, pages 477-481.
Crossref
Thangam Venkatesan, David J. Levinthal, B U. K. Li, Sally E. Tarbell, Kathleen A. Adams, Robert M. Issenman, Irene Sarosiek, Safwan S. Jaradeh, Ravi N. Sharaf, Shahnaz Sultan, Christopher D. Stave, Andrew A. Monte & William L. Hasler. (2019) Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterology & Motility 31:S2.
Crossref
Yih-Chieh Chen & Jean E. Klig. (2019) Cannabis-related emergencies in children and teens. Current Opinion in Pediatrics 31:3, pages 291-296.
Crossref
Samuel D. Banister, Jonathon C. Arnold, Mark Connor, Michelle Glass & Iain S. McGregor. (2019) Dark Classics in Chemical Neuroscience: Δ 9 -Tetrahydrocannabinol . ACS Chemical Neuroscience 10:5, pages 2160-2175.
Crossref
Eike Blohm, Peter Sell & Mark Neavyn. (2019) Cannabinoid toxicity in pediatrics. Current Opinion in Pediatrics 31:2, pages 256-261.
Crossref
Joseph V. Pergolizzi Jr.Jo Ann LeQuang & John F. Bisney. (2018) Cannabinoid Hyperemesis. Medical Cannabis and Cannabinoids 1:2, pages 73-95.
Crossref
Kamal Kant Sahu, Ajay Mishra & Leily Naraghi. (2019) Erythema ab igne as a complication of cannabinoid hyperemesis syndrome. BMJ Case Reports 12:1, pages e227836.
Crossref
David H. Cisewski & Sergey M. Motov. (2019) Essential pharmacologic options for acute pain management in the emergency setting. Turkish Journal of Emergency Medicine 19:1, pages 1-11.
Crossref
F. James Squadrito & Clare Roepke. 2019. Gastrointestinal Emergencies. Gastrointestinal Emergencies 127 129 .
George Sam Wang & Christopher Hoyte. (2018) Common Substances of Abuse. Pediatrics In Review 39:8, pages 403-414.
Crossref
Dale E. Bjorling & Zun-yi Wang. (2018) Potential of Endocannabinoids to Control Bladder Pain. Frontiers in Systems Neuroscience 12.
Crossref
Neera Khattar & Joanne C. Routsolias. (2018) Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review. American Journal of Therapeutics 25:3, pages e357-e361.
Crossref
John R. Richards. (2018) Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department. The Journal of Emergency Medicine 54:3, pages 354-363.
Crossref
KRISTOPHER A. KAST & LILIYA GERSHENGOREN. (2018) Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice. Journal of Psychiatric Practice 24:1, pages 51-55.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Lisa T. Hong, Jennifer Ku, Alisyn L. May, Alexander Wisner, F. Scott Hall & Sidhartha D. Ray. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 29 89 .
Maude Marillier, Anne Batisse, Yves Edel, An-Hung Nguyen, Cécile Chevallier, Grégory Pfau, Philippe Podevin & Samira Djezzar. (2017) Cannabinoid Hyperemesis Syndrome (CHS). Journal of Clinical Psychopharmacology 37:6, pages 739-743.
Crossref
Dorothy James Moore. (2017) Cannabinoid hyperemesis syndrome. Nursing Made Incredibly Easy! 15:6, pages 51-54.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.